Neeraj Agarwal, MD, FASCO
@neerajaiims
Followers
16K
Following
23K
Media
2K
Statuses
14K
Medical Oncologist. Editor-in-chief: @ASCO Daily News; Presidential Endowed Chair, @HuntsmanCancer (NCI-CCC) @UUtah, FCOI https://t.co/ywWAdZmBWt
Salt Lake City, UT
Joined January 2016
Just came online in @TheLancet 👉Our two papers on improved OS with Enzalutamide + Talazoparib in mCRPC #ProstateCancer in all-comer & HRRm patients (Median OS and HRs👇). Weblinks to the papers👉 and @PCFnews @urotoday @OncoAlert
Just in👉Two @TheLancetOncol papers on patient-reported QOL results in ph3 TALAPRO-2 trial👉in all-comer & HRR deficient mCRPC #ProstateCancer pts👉Improved OS without compromising QOL👇Links: & @urotoday @OncoAlert @PCFnews 👇
12
63
162
RT @Garg_H: Excited to host @neerajaiims @shilpaonc @DharamKaushik5 @DrYukselUrun @ravikanesvaran at GUONCOCON2025 in Delhi… a true MDT mee….
0
4
0
RT @montypal: Until we have randomized studies, we will not truly understand the contribution of IO in TKI/IO combinations for non-clear ce….
0
11
0
RT @huntsmancancer: Zeynep Ozay, MD (@ziremozay) saw firsthand how cancer research shaped treatment decisions in the clinic. Now, as a post….
0
6
0
Loved the wonderful talk by @AlbigesL at #IUCS25 👉 On biomarkers in #kidneycancer 👉 tumor PD-L1 expression, blood based KIM-1 and MAdCAM-1, patient selection for microbiome Rx, and more👉new era of biomarker investigation in RCC @OncoAlert @kidneycan @urotoday
Excellent insights from L. Albiges on biomarkers in RCC. No routine marker yet, but KIM-1, sarcomatoid, microbiome and more are under study. Pragmatic approach needed!. #IUCS25 #KidneyCancer .@urologysummit @gbanna74 @ravikanesvaran @OncoAlert @ONCOassist @neerajaiims
1
13
25
Brilliant talk by @montypal #IUCS25 👉 .On adjuvant & microbiome Rx of #kidneycancer 👉awaiting results of Rampart and Litespark-022 adjuvant trials & work by @NazliDizman @EbrahimiHedyeh leading to @SWOG mRCC trial by @PBarataMD @DrVaishampayan @OncoAlert @urotoday @kidneycan
1
21
39
Another masterclass by the master @PGrivasMDPhD at #IUCS25 👉 .Ongoing trials of peri-op immunotherapy in MIBC #bladdercancer , role of ctDNA-guided Rx, & take home message. @BladderCancerUS @urotoday @OncoAlert
Tour de force by Petros Grivas at #IUCS25. From peri-op immunotherapy in MIBC to ctDNA-guided insights showing how trials like NIAGARA are reshaping the future of bladder cancer care. @urologysummit @gbanna74 @ravikanesvaran @OncoAlert @ONCOassist @neerajaiims @PGrivasMDPhD
0
19
29
Excellent talk by @drenriquegrande at #IUCS25 👉improving therapy of mUC #bladdercancer 👉 oncologists prioritize survival data, & patients favor quality of life👇 @BladderCancerUS @urotoday @OncoAlert @gbanna74
1
23
28
RT @montypal: Excited to serve as captain of #UromigosTeamNA, which will be competing in #UromigosLive25. @tompowles1 & @brian_rini have as….
0
12
0
RT @OncoAlert: A GREAT START TO #IUCS25 🇬🇧in Portsmouth as REPORTED by MedTrack Social @OncoReporte. . USE MEDTRACK….
0
10
0
RT @nataliagandur: ⭐ Excellent oral at #IUCS25."Toward precision oncology".@neerajaiims @urologysummit @OncoAlert.🎓@gbanna74 🎓@ravikanesvar….
0
18
0
RT @OncoAlert: A Great Day One of #IUCS25. Translating Trial endpoints into clinically meaningful decision by Dr. Alison Tree.💡 Key Takeaw….
0
12
0
RT @OncoAlert: A GREAT START TO #IUCS25 🇬🇧in Portsmouth.as REPORTED by MedTrack Social @OncoReporte . USE MEDTRACK….
0
11
0
RT @OncoAlert: A Great Day One of #IUCS25 Great Presentation by Dr. Partha Choudhury . The Theranostic Revolution .✨ Early randomized resul….
0
8
0
Loved the talk on the heart health in #prostatecancer pts starting androgen deprivation therapy by #AmitBahl @BristolCancer 👉”ABCDE” of cardio protection👇 #IUCS25 @PCFnews @urotoday @OncBrothers @OncoAlert @American_Heart @ASCO
✅ Insightful talk at #IUCS25."ADT in prostate cancer – Getting to the heart of the matter".Prof Amit Bahl @urologysummit @OncoAlert 🎓@gbanna74 🎓@ravikanesvaran. 🔹 Cardiovascular disease = leading cause of death in men with prostate cancer ⚠️.🔹 ADT increases risk via
3
20
24
What do our patients with #prostatecancer want? Wonderful talk by @allison_tree at #IUCS25 👉ready to accept 1.5% drop in life expectancy for each 1% increase in self-care ability & more👇@PCFnews @urotoday @OncBrothers @OncoAlert
Very insightful talk by Alison Tree at #IUCS25. Translating trial endpoints into decisions that truly matter for patients, reminding us that more dose isn’t always more life, and survival curves are real people. @urologysummit @gbanna74 @ravikanesvaran @OncoAlert @ONCOassist
1
19
33
RT @nataliagandur: 🌟🎓Honored to be part of #IUCS25, a terrific program by @gbanna74 & @ravikanesvaran 🙌.An outstanding agenda covering kidn….
0
7
0
RT @DrYukselUrun: Call for abstracts is open. APCCC 2026 (Lugano, 30 Apr–2 May) is a space where evidence meets consensus in advanced prost….
0
8
0
RT @DrChoueiri: New paper from the @AmericanCancer group published @CACancerJournal focused on prostate cancer . @….
0
22
0